Table IV.
Haplotype results stratified by age at diagnosis
| Dataset | Gene | Haplotype | Haplotype frequency (%) | OR (95% CI)a | P-value (t-statistic)a |
| Age ≥ 50 | CASP8b | GC | 89.7 | Reference | — |
| CT | 10.0 | 0.79 (0.64–0.98) | 0.03 | ||
| FGFR2c | GCAC | 48.3 | Reference | — | |
| ATGT | 30.2 | 1.37 (1.18–1.58) | 2.51E-05 | ||
| GTGT | 9.0 | 1.39 (1.08–1.80) | 0.01 | ||
| GTAC | 2.9 | 1.25 (0.83–1.87) | 0.29 | ||
| GTAT | 3.9 | 1.29 (0.90–1.86) | 0.16 | ||
| ATAC | 2.2 | 1.55 (0.98–2.44) | 0.06 | ||
| GCAT | 1.0 | 0.85 (0.43–1.68) | 0.63 | ||
| ATGC | 1.3 | 1.35 (0.75–2.45) | 0.32 | ||
| TNRC9d | AC | 45.9 | Reference | — | |
| AT | 5.6 | 0.96 (0.70–1.33) | 0.82 | ||
| GC | 16.6 | 0.95 (0.79–1.15) | 0.61 | ||
| GT | 31.8 | 1.03 (0.89–1.19) | 0.69 | ||
| Age < 50 | CASP8b | GC | 89.5 | Reference | — |
| CT | 10.3 | 1.04 (0.84–1.29) | 0.74 | ||
| FGFR2c | GCAC | 48.0 | Reference | — | |
| ATGT | 31.2 | 1.14 (0.98–1.32) | 0.10 | ||
| GTGT | 8.8 | 1.35 (1.02–1.78) | 0.03 | ||
| GTAC | 3.1 | 0.99 (0.64–1.53) | 0.95 | ||
| GTAT | 3.0 | 1.30 (0.85–1.99) | 0.22 | ||
| ATAC | 2.4 | 1.01 (0.64–1.59) | 0.98 | ||
| GCAT | 1.1 | 0.61 (0.31–1.22) | 0.16 | ||
| GCGT | 1.2 | 0.80 (0.43–1.48) | 0.47 | ||
| TNRC9d | AC | 44.9 | Reference | — | |
| AT | 5.5 | 1.10 (0.79–1.54) | 0.58 | ||
| GC | 16.0 | 0.97 (0.79–1.19) | 0.76 | ||
| GT | 33.5 | 1.17 (1.01–1.36) | 0.04 |
Adjusted for age, race, European ancestry and offset term.
CASP8 SNPs are rs1045485 and rs17468277 in relative nucleotide location order.
FGFR2 SNPs are rs11200014, rs2981579, rs1219648 and rs2420946 in relative nucleotide location order.
TNRC9 SNPs are rs12443621 and rs3803662 in relative nucleotide location order.